Document:

Exhibit
10.6

 

 

EMPLOYMENT
AGREEMENT

 

This
Employment Agreement (the “Agreement”) is made effective as described below in Section 1 by and between Biofrontera, Inc,
a Delaware corporation (the “Company”) having its registered office at 120 Presidential Way, Suite 330, Woburn, MA 01801
and Erica Monaco (the “Executive”) currently employed as Chief Financial Officer for Biofrontera Inc.

 

BACKGROUND
INFORMATION

 

The
Company wishes to secure the employment services of the Executive for an indefinite period of time and upon the particular terms and
conditions hereinafter set forth. The Executive is willing to be so employed. Accordingly, the parties agree as follows:

 

OPERATIVE
PROVISIONS

 

		1.	EMPLOYMENT
                                            AND TERM

 

This
Agreement shall become effective upon Company’s successful completion of an Initial Public Offering according to its Registration
Statement on Form S-1 (the “Effective Date”). This Agreement shall remain in full force and effect for an indefinite period
of time and is subject to termination pursuant to Section 9 of the Agreement.

 

The
Company currently employs the Executive. It is agreed that the Executive will devote 100% of her working capacity to the performance
of her duties hereunder. This Agreement shall remain in full force and effect for an indefinite period of time and is subject to termination
pursuant to Section 9 of the Agreement. 

 

		2.	DUTIES

 

During
the term of the Agreement, whether initial or extended, the Executive shall render to the Company services as Chief Executive Officer
of the Company and shall perform such duties as may be designated by and subject to the supervision of the Company’s Board of Directors.
Executive shall serve in such additional capacities appropriate to her responsibilities and skills as shall be designated by the Board
of Directors.

 

During
such period, the Executive shall devote her full attention, time and energies as necessary to the business affairs of the Company (subject
to the terms of Section 1 above and Section 5 below) and will use her reasonable business efforts to promote the interests and reputation
of the Company. She may pursue non-competitive employment activities that do not interfere with the complete performance of her obligations
hereunder only after prior written agreement by the Company’s Board of Directors.

 

    	1

     

    

 

The
parties hereby acknowledge that Executive’s title “Chief Executive Officer” may change during the term of this Agreement.
The parties agree that the occurrence of such a change will not constitute a beach of this Agreement, so long as i) Executive’s
responsibilities are not significantly diminished from her current working capacity, and ii) Executive’s title is replaced with
another “C-Level” title (i.e. Chief Financial Officer or Chief Operations Officer).

 

		3.	LOCATION
                                            OF EMPLOYMENT

 

Executive’s
principal place of employment shall be at the Company’s headquarters, which is currently located in Woburn, MA. Executive shall
also be required to conduct reasonable business travel as directed by the Board of Directors and consistent with the Executive’s
duties and responsibilities.

 

		4.	COMPENSATION

 

For
the services to be rendered by the Executive under the Agreement, the Company shall pay her a salary while she is rendering such services
and performing her duties hereunder, and the Executive shall accept such salary as full payment for such service. Executive’s annual
base salary shall be $300,000.00, reduced by (i) Federal income tax withholding, (ii) FICA; and (iii) such other reductions as may be
agreed upon by the parties or required by law. The salary shall be paid in bi-weekly installments and in accordance with the Company’s
customary payroll procedure. For each fiscal year in effect during the active life of this Agreement, the Executive shall be eligible
to receive a cash bonus of up to 30% of her base salary (the “Target Bonus”) upon the attainment of performance goals set
in advance by the Board of Directors. All such bonuses shall be paid after the completion of the Company’s financial statements
for the applicable fiscal year as and when bonuses are paid to members of senior management generally. The actual amount of Executive’s
bonus shall depend upon the level of achievement of set targets, however no bonus shall be paid if the level of target achievement is
below 70%. 

 

Company
shall also pay to Executive a one-time signing bonus of $75,000.00 (subject to applicable tax withholdings). This sum shall be paid in
two installments: i) $37,500.00 on the first regularly scheduled pay date after the effective date of this Agreement, and ii) $37,500.00
on the final pay date of 2021 (provided that this Agreement has not been terminated by either party in accordance with Section 9 of this
Agreement prior to said date).

 

Upon
the Executive’s termination of employment, regardless of the reason for such termination and regardless of the party by whom such
termination is initiated, the Executive shall be entitled to immediate payment of all accrued but unpaid base salary and expenses owed.
In addition, upon the Executive’s termination of employment by the Company other than termination for “Cause” under
Section 9(d) of the Agreement, the Executive shall be entitled to a severance payment equal to one twelfth the Executive’s then-current
annual base salary for each full year the Executive has been employed by the Company; provided, however, that such payment shall not
exceed two full years of Executive’s then-current base salary.

 

Further,
the Executive shall participate in Company’s stock option plan. The number of options rewarded to her shall be at the discretion
of the Board of Directors.

 

    	2

     

    

 

		5.	VACATION;
                                            FRINGE BENEFITS; REIMBURSEMENT OF EXPENSES

 

The
Executive shall be entitled to paid time off in accordance with the Company’s standard policy. She shall not be entitled to receive
monetary or other valuable consideration for vacation time to which she is entitled but does not take, unless so ordered by the Board
of Directors. Timing of vacations shall be reasonably exercised by the Executive.

 

During
her period of employment hereunder, the Executive shall further be entitled to (a) such leave by reason of physical or mental disability
or incapacity and to such participation in medical and life insurance, pension benefits, disability and other fringe benefit plans as
the Company may make generally available to all of its executive employees and other employees from time to time; subject, however, as
to such plans, to such budgetary constraints or other limitations as may be imposed by the Board of Directors of the Company from time
to time; and (b) reimbursement for all normal and reasonable expenses necessarily incurred by her in the performance of her obligations
hereunder, subject to such reasonable substantiation requirements as may be imposed by the Company to all employees of the Company, unless
otherwise agreed to by the Board of Directors.

 

		6.	CONFIDENTIAL
                                            INFORMATION AND PROPRIETARY INTERESTS

 

Executive
acknowledges that she has received and will continue to receive Company’s Confidential Information. Executive recognizes that all
such Confidential Information is and shall remain the sole property of the Company, free of any rights of Executive, and acknowledges
that the Company has a vested interest in assuring that all such Confidential Information remains secret and confidential. Therefore,
Executive agrees that during or after the expiration of her term of employment with the Company, the Executive shall not communicate
or divulge to, or use for the benefit of, any individual, association, partnership, trust, corporation or other entity except the Company,
any Confidential Information received by the Executive by virtue of her employment, without first being in receipt of the Company’s
written consent to do so.

 

For
the purposes of this Agreement, the term “Confidential Information” means:

 

	a.	All
    information developed or used by the Company or its associates relating to business operations, including but not limited to customer
    lists, purchase orders, supplier or distributor information, financial data, pricing information and price lists, business plans,
    marketing strategies, personnel records, and all books, records, manuals, advertising materials, catalogues, correspondences, mailing
    lists, production data, and purchasing materials; and

 

    	3

     

    

 

	b.	All
    proprietary information of the company (or any records related to the same), including but not limited to all trade secrets, inventions,
    processes, procedures, research records, market surveys or marketing know-how, trademarks, copyrights, patents, and patent applications.
    

 

The
term “Confidential Information” shall not include information that is or becomes generally known to the public other than
as a result of a disclosure by Executive in violation of this Agreement, or by any other employee of the Company subject to confidentiality
obligations.

 

		7.	NON-COMPETITION/NON-SOLICITATION

 

During
the term of her employment hereunder and for the one (1) year period following the termination hereof for any reason other than (a) the
Company’s discontinuance of activities; or (b) an adjudication of the Company’s material breach of any of its obligations
set forth in Sections 1, 2,4, and 5 inclusive, the “Restricted Period”) the Executive shall not, without prior written consent
by the Board of Directors of the Company, directly or indirectly, engage in or become an owner of, render any service to, enter the employment
of, or represent or solicit for any business which competes with any activity of the Company conducted at any time during the Executive’s
period of employment and which is located in the United States. The parties expressly agree that the duration and geographical area of
the restrictive covenant are reasonable.

 

The
covenant shall be construed as an agreement independent of any other provision herein; and the existence of any claim or cause of action
of the Executive against the Company regardless of how arising, shall not constitute a defense to the enforcement by the Company or its
terms. If any portion of the covenant is held by a court to be unenforceable with respect either to its duration or geographical area,
for whatever reason, it shall be considered divisible both as to time and geographical area, resulting in an intended requirement that
the longest lesser period of time or largest lesser geographical area found by such court to be a reasonable restriction shall remain
an effective restrictive covenant, specifically enforceable against the Executive.

 

Notwithstanding
any statement contained in this Section to the contrary, legal or beneficial ownership by the Executive of a less than five percent (5%)
interest in a competitive corporation the stock of which is publicly traded on a stock exchange or by means of an electronic dealer quotation
system, shall not of itself be deemed to constitute a breach by the Executive of the terms hereof.

 

Additionally,
during the Executive’s employment with the Company and thereafter during the Restricted Period, the Executive shall not, and shall
not permit any third party subject to Executive’s direction or control to, directly or indirectly, (i) call upon, accept business
from, or solicit the business of any Person who is, or who had been at any time during the preceding twelve months, a customer of the
Company, (ii) otherwise divert or attempt to divert any business from the Company, (iii) interfere with the business relationships between
the Company and any of its customers, suppliers or others with whom they have business relationships or (iv) recruit or otherwise solicit
or induce, or enter into or participate in any plan or arrangement to cause, any Person who is an employee of, or otherwise performing
services for, the Company to terminate his or her employment or other relationship with the Company, or hire any Person who has left
the employ of or ceased providing services to the Company during the Restricted Period.

 

    	4

     

    

 

		8.	REMEDIES
                                            FOR BREACH OF EXECUTIVE OBLIGATIONS

 

The
parties to the agreement agree that the services of the Executive are of a personal, specific, unique and extraordinary character and
cannot be readily replaced by the Company. They further agree that in the course of performing her services, the Executive will have
access to various types of proprietary information of the Company, which, if released to others or used by the Executive other than for
the benefit of the Company, in either case without the Company’s written consent, could cause the Company to suffer irreparable
injury. Therefore, the obligation of the Executive established under Section 6 and Section 7 hereof shall be enforceable both at law
and in equity, by injunction, specific performance, damages or other remedy; and the right of the Company to obtain any such remedy shall
be cumulative and not alternative and shall not be exhausted by any one or more uses thereof. Any adjudication against Executive by the
Company shall be in accordance with the laws of Massachusetts and Massachusetts employee rights.

 

		9.	MODIFICATION
                                            AND TERMINATION

 

	a.	Modification.
    The Agreement may be amended or modified only with the mutual written consent of the parties, and in its present form consists
    of the entire Agreement between and amongst the parties.
	 	 
	b.	Termination-General.
    The Agreement may be terminated by either party for any reason by giving six (6) months’ notice to the other party. The
    Agreement may be terminated by the Company upon the occurrence of any one of the following events: (a) the death of the Executive;
    (b) the occurrence to Executive of a physical or mental disability which, in the judgment (reasonably exercised) of the Board of
    Directors, renders her unable to perform her normal duties on behalf of the Company for a continuous period of six (6) months (measured
    from the first day of the month immediately following the occurrence of such disability); or (c) a determination by the Board of
    Directors that there is “Cause” (as described in section d below) to terminate Executive’s employment.
	 	 
	c.	By
    Death or Disability. In the event of the Executive’s death, her base compensation otherwise due for the succeeding
    period of time but no less than three (3) full calendar months following her death shall be paid to her designated beneficiary, or
    to her estate if no beneficiary has been designated. In the event of her disability the Executive shall be paid her compensation
    for the succeeding period of time but no less than three (3) months. Thereafter for the succeeding three (3) months shall be treated
    as being on an authorized unpaid leave of absence.
	 	 
	d.	For
    Cause. For purposes of the Agreement, the term “Cause” shall include, but not be limited to (i) the Executive’s
    willful misconduct or gross negligence; (ii) her conscious disregard of her obligations hereunder or of any other duties reasonably
    assigned to her by the Board of Directors; (iii) her repeated conscious violation of any provision of the law, the Company’s
    By-Laws or of its other stated policies, standards, practices, regulations or procedures; (iv) her commission of any act involving
    moral turpitude; (v) a determination that she has demonstrated a dependence upon any addictive substance, including but not limited
    to alcohol, controlled substances, narcotics or barbiturates; or (vi) continued, willful and deliberate non-performance by the Executive
    of her duties hereunder (other than by reason of the Executive’s physical or mental illness, incapacity or disability) which
    has continued for more than 30 days following written notice of such non-performance from the Board of Directors.
	 	 

    	5

     

    

 

	e.	Continued
    Effectiveness of Certain Obligations. No termination or expiration of the Agreement, whether consummated by action of either
    party or by operation of the terms hereof, shall relieve the Executive from her continued performance of the obligations established
    under Sections 6 and 7 hereof.
	 	 
	f.	Resignation
    as an Officer or Director. Immediately upon any termination of Executive’s employment for any reason, Executive shall
    be deemed to have resigned any position she may then hold as an officer of the Company and/or as a fiduciary of any Company benefit
    plan. 

 

		10.	Change
                                            of Control

 

If
Executive’s termination of employment occurs within 3 months prior to or 12 months after a “Change in Control” as defined
in this Section and such termination is by the Company without “Cause,” (i) Executive would be entitled to receive, in lieu
of the severance amount described in Section 4, a severance amount equal to the sum of her current base salary and target annual bonus
for the then current fiscal year (or if higher, the target annual bonus for the fiscal year immediately prior to the Change in Control),
and (ii) Subject to the Executive’s copayment of premium amounts at the active employees’ rate, the Executive may continue
to participate in the Company’s group health, dental and vision program for 12 months; provided, however, that the continuation
of health benefits under this Section shall reduce and count against the Executive’s rights under COBRA.

 

For
the purposed of this Agreement, a “Change in Control” shall mean the occurrence of any of the following events: 

 

	a.	The
    approval by stockholders of the Company of: 

 

	 	1.	Any
    consolidation or merger of the Company in which the company is not the continuing or surviving corporation, or 
	 	 	 
	 	2.	A
    sale, lease, exchange or other transfer (in one transaction or a series of related transactions) of all or substantially all the
    assets of the Company to a party which is not controlled by the Company’s parent company; 

 

	b.	Either:
    

 

	 	1.	The
    receipt by the Company of a report on schedule 13D, or an amendment to such a report, filed with the Securities and Exchange Commission
    (“SEC”) pursuant to Section 13(d) of the Securities Exchange Act of 1934 (the “1934 Act”) disclosing that
    any person, group, corporation or other entity (a “Person”) is the beneficial owner, directly or indirectly, of 50% or
    more of the outstanding stock of the Company, or 
	 	 	 
	 	2.	The
    actual knowledge by the Company of facts, on the basis of which any person is required to file such a report on schedule 13D, or
    an amendment to such a report, with the SEC (or would be required to file such a report or amendment upon the lapse of the applicable
    period of time specified in Section 13(d) of the 1934 Act) disclosing that such a person is the beneficial owner, directly or indirectly,
    of 50% or more of the outstanding stock of the Company;

 

    	6

     

    

 

	c.	The
    purchase by any person (as defined in Section 13(d) of the 1934 Act), corporation or other entity, other than the Company or a wholly
    owned subsidiary or the parent company of the Company, of shares pursuant to a tender or exchange offer, to acquire any stock of
    the Company (or securities convertible into stock) for cash, securities or any other consideration provided that, after consummation
    of the offer, such person, group, corporation or other entity is the beneficial owner (as defined in rule 13d-3 under the 1934 Act),
    directly or indirectly, of 50% or more of the outstanding stock of the Company (calculated as provided in paragraph (d) of Rule 13d-3
    under the 1934 act in the case of rights to acquire stock); or 
	 	 
	d.	The
    combination or merger of the Company with another company in which the Company is the surviving corporation but, immediately after
    the combination, the shareholders of the Company immediately prior to the combination do not hold, directly or indirectly, more than
    50% of the voting stock of the combined company (therefore being excluded from the number of shares held by such shareholders, but
    not from the voting stock of the combined company, any shares received by affiliates (as defined in the rules of the Securities and
    Exchange Commission) of such other company in exchange for stock of such other company).

 

		11.	INDEBTEDNESS
                                            OF EXECUTIVE

 

If,
during the course of her employment, Executive becomes indebted to the Company for any reason, the Company shall, if it so elects, have
the right to set off and to collect any sums due it from the Executive out of any amounts which it may owe to the Executive for unpaid
compensation. In the event that the Agreement terminates for any reason, all sums owed by the Executive to the Company shall become immediately
due and payable.

 

		12.	MISCELLANEOUS
                                            PROVISIONS

 

	a.	Non-assignment:
    Neither the Agreement nor any right or interest hereunder shall be assigned by the Executive or her legal representatives.
	 	 
	b.	Enforcement:
     If any term or condition or the Agreement shall be invalid or deemed unenforceable to any extent or in any application,
    then the remainder of the Agreement, and such terms or conditions except to such extent or in such application, shall not be affected
    thereby, and each and every term and condition of the Agreement shall be valid and enforced to the fullest extent and in the broadest
    application permitted by law.
	 	 
	c.	Notice:
     All notices or other communications required or permitted to be furnished pursuant to the Agreement shall be in writing
    and shall be considered as delivered when received by the recipient.
	 	 

    	7

     

    

 

	d.	Application
    of Massachusetts Law: The Agreement, and the application or interpretation thereof, shall be governed exclusively by its
    terms and by the laws of the State of Massachusetts. Venue shall be deemed located in Middlesex County, Massachusetts.
	 	 
	e.	Counterparts:
    The Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which
    together shall constitute on and the same instrument.
	 	 
	f.	Binding
    Effect: Each of the provisions and agreements herein contained shall be binding upon and inure to the benefit of the personal
    representatives, devisees, heirs, successors, transferees and assigns of the respective parties hereto.
	 	 
	g.	Cooperation: During and following the active
    life of this Agreement, Executive shall give Executive’s assistance and cooperation willingly, upon reasonable notice (which
    shall include due regard to the extent reasonably feasible for Executive’s employment obligations and prior commitments), in
    any matter relating to Executive’s position with the Company or Executive’s knowledge as a result thereof as the company
    may reasonably request, including Executive’s attendance and truthful testimony where deemed appropriate by the Company, with
    respect to any investigation or the Company’s defense or prosecution of any existing or future claims or litigations or other
    proceeding relating to matters in which she was involved or had knowledge by virtue of Executive’s employment with the Company.
    The Company will reimburse Executive for reasonable out-of-pocket travel costs and expenses incurred by her (in accordance with Company
    policy) as a result of providing such assistance.
	 	 
	h.	Legal
    Fees and Costs: If a legal action is initiated by Executive against the Company, arising out of or relating to the alleged
    performance or non-performance of any right or obligation established hereunder, or any dispute concerning the same, any and all
    fees, costs and expenses reasonably incurred by the Company in investigating, preparing for, defending against, or providing evidence,
    producing documents or taking any other action in respect of, such action shall be the joint and several obligation of and shall
    be paid or reimbursed by Executive only if Executive is the unsuccessful party. If any other legal action (other than that which
    is referenced above) is initiated by a party to the Agreement against another, arising out of or relating to the alleged performance
    or non-performance of any right or obligation established hereunder, or any dispute concerning the same, each party shall be responsible
    for its own fees, costs and expenses reasonably incurred in investigating, preparing for, prosecuting, defending against, or providing
    evidence, producing documents or taking any other action in respect thereof.
	 	 
	i.	Indemnification:    The Company hereby agrees to indemnify Executive and hold her harmless to the fullest extent permitted by law and under the
    bylaws of the Company against and in respect to any and all actions, suits, proceedings, claims, demands, judgements, costs, expenses
    (including reasonable attorney’s fees), losses, and damages resulting from Executive’s good faith performance of her
    duties and obligations with the Company, except in the case of gross negligence or willful misconduct, whether or not such claims,
    demands, judgements, costs, expenses, losses, and damages are asserted or filed during the active life of this Agreement. 
	 	 
	j.	Survival: The Parties’ obligations
    under Sections 6, 7, 8, 10, 11, and 12 shall survive the Termination of this agreement.

 

    	8

     

    

 

	IN WITNESS WHEREOF, the parties have executed the Agreement,
	 	 
	 	 
	/s/
    Hermann Luebbert	
	Chairman
    of the Board of Directors	 
	 	 
	 	 
	/s/
    Erica Monaco 8/11/21	 
	Erica
    Monaco	 

 

    	9Exhibit
10.11

 

 

EMPLOYMENT
AGREEMENT

 

This
Employment Agreement (the “Agreement”) is made effective as described below in Section 1 by and between Biofrontera, Inc,
a Delaware corporation (the “Company”) having its registered office at 120 Presidential Way, Suite 330, Woburn, MA 01801
and Hermann Luebbert (the “Executive”) of Hoehenstrasse 59, 51381 Leverkusen, Germany.

 

BACKGROUND
INFORMATION

 

The
Company wishes to secure the employment services of the Executive for an indefinite period of time and upon the particular terms and
conditions hereinafter set forth. The Executive is willing to be so employed. Accordingly, the parties agree as follows:

 

OPERATIVE
PROVISIONS

 

	1.	EMPLOYMENT
                                            AND TERM

 

This
Agreement shall become effective upon Company’s successful completion of an Initial Public Offering according to its Registration
Statement on Form S-1 (the “Effective Date”). This Agreement shall remain in full force and effect for an indefinite period
of time and is subject to termination pursuant to Section 9 of the Agreement.

 

Upon
execution of this Agreement, Executive is employed as the Chief Executive Officer of Biofrontera AG. While Executive remains so employed
and the contract with Biofrontera AG remains valid in all aspects (with the exception that Executive’s base salary may be decreased
to 70% of its full value), he shall devote approximately 30% of his working capacity to his duties hereunder. However, upon termination
of his employment with Biofrontera AG (and subject to the terms of Section 4 regarding the step-up in compensation), it is agreed that
the Executive will devote 100% of his working capacity to the performance of his duties hereunder.

 

	2.	DUTIES

 

During
the term of the Agreement, whether initial or extended, the Executive shall render to the Company services as Executive Chairman and
shall perform such duties as may be designated by and subject to the supervision of the Company’s Board of Directors. Executive
shall serve in such additional roles appropriate to his responsibilities and skills as shall be designated by the Board of Directors.

 

During
such period, the Executive shall devote his full attention, time and energies as necessary to the business affairs of the Company (subject
to the terms of Section 1 above and Section 5 below) and will use his reasonable business efforts to promote the interests and reputation
of the Company. He may pursue non-competitive employment activities that do not interfere with the complete performance of his obligations
hereunder only after prior written agreement by the Company’s Board of Directors.

 

    	1

    	 

    

 

	3.	LOCATION
                                            OF EMPLOYMENT

 

Executive’s
principal place of employment shall be at the Company’s headquarters, which is currently located in Woburn, MA. However, Executive
will be permitted to work entirely remotely from his home or another convenient office location, as needed and as determined by Executive.
Nonetheless, Executive shall also be required to conduct reasonable business travel as directed by the Board of Directors and consistent
with the Executive’s duties and responsibilities.

 

	4.	COMPENSATION

 

For
the services to be rendered by the Executive under the Agreement, the Company shall pay him a salary while he is rendering such services
and performing his duties hereunder, and the Executive shall accept such salary as full payment for such service, as follows:

 

	 	-	Initially,
    Executive’s annual base salary shall be $174,000.00 (representing 30% of his full base salary during the time in which 30%
    of his working capacity will be devoted to the Company.) 
	 	 	 
	 	-	Starting
    on the first full pay period following his termination of his employment from Biofrontera AG, and with the approval and consent of
    the Board of Directors, Executive’s base salary shall be $580,000.00.

 

The
salary shall be reduced by (i) Federal income tax withholding, (ii) FICA; and (iii) such other reductions as may be agreed upon by the
parties or required by law, and shall be paid in bi-weekly installments and in accordance with the Company’s customary payroll
procedure. For each fiscal year in effect during the active life of this Agreement, the Executive shall be eligible to receive a cash
bonus of up to 100% of his base salary (the “Target Bonus”) upon the attainment of performance goals set in advance by the
Board of Directors. All such bonuses shall be paid after the completion of the Company’s financial statements for the applicable
fiscal year as and when bonuses are paid to members of senior management generally. The actual amount of Executive’s bonus shall
depend upon the level of achievement of set targets, however no bonus shall be paid if the level of target achievement is below 70%.

 

Upon
the Executive’s termination of employment, regardless of the reason for such termination and regardless of the party by whom such
termination is initiated, the Executive shall be entitled to immediate payment of all accrued but unpaid base salary and expenses owed.
In addition, upon the Executive’s termination of employment by the Company other than termination for “Cause” under
Section 9(d) of the Agreement, the Executive shall be entitled to a severance payment equal to one twelfth the Executive’s then-current
annual base salary for each full year the Executive has been employed by the Company (including Biofrontera AG, as a past affiliate of
the Company); provided, however, that such payment shall not exceed two full years of Executive’s then-current base salary.

 

Further,
the Executive shall participate in Company’s stock option plan. The number of options rewarded to him shall be at the discretion
of the Board of Directors.

 

    	2

    	 

    

 

	5.	VACATION;
                                            FRINGE BENEFITS; REIMBURSEMENT OF EXPENSES

 

The
Executive shall be entitled to paid time off in accordance with the Company’s standard policy. He shall not be entitled to receive
monetary or other valuable consideration for vacation time to which he is entitled but does not take, unless so ordered by the Board
of Directors. Timing of vacations shall be reasonably exercised by the Executive.

 

During
his period of employment hereunder, the Executive shall further be entitled to (a)leave by reason of physical or mental disability or
incapacity, (b) participation in medical and life insurance, pension, disability and other fringe benefit plans as the Company may make
generally available to all of its executive employees and other employees from time to time; subject, however, to such budgetary constraints
or other limitations as may be imposed by the Board of Directors of the Company from time to time; and (c) reimbursement for all normal
and reasonable expenses necessarily incurred by his in the performance of his obligations hereunder, subject to such reasonable substantiation
requirements as may be imposed by the Company to all employees of the Company, unless otherwise agreed to by the Board of Directors.

 

	6.	CONFIDENTIAL
                                            INFORMATION AND PROPRIETARY INTERESTS

 

Executive
acknowledges that he has received and will continue to receive Company’s Confidential Information. Executive recognizes that all
such Confidential Information is and shall remain the sole property of the Company, free of any rights of Executive, and acknowledges
that the Company has a vested interest in assuring that all such Confidential Information remains secret and confidential. Therefore,
Executive agrees that during or after the expiration of his term of employment with the Company, the Executive shall not communicate
or divulge to, or use for the benefit of, any individual, association, partnership, trust, corporation or other entity except the Company,
any Confidential Information received by the Executive by virtue of his employment, without first being in receipt of the Company’s
written consent to do so.

 

For
the purposes of this Agreement, the term “Confidential Information” means:

 

	a.	All
    information developed or used by the Company or its associates relating to business operations, including but not limited to customer
    lists, purchase orders, supplier or distributor information, financial data, pricing information and price lists, business plans,
    marketing strategies, personnel records, and all books, records, manuals, advertising materials, catalogues, correspondences, mailing
    lists, production data, and purchasing materials; and
	 	 
	b.	All
    proprietary information of the company (or any records related to the same), including but not limited to all trade secrets, inventions,
    processes, procedures, research records, market surveys or marketing know-how, trademarks, copyrights, patents, and patent applications.
    

 

    	3

    	 

    

 

The
term “Confidential Information” shall not include information that is or becomes generally known to the public other than
as a result of a disclosure by Executive in violation of this Agreement, or by any other employee of the Company subject to confidentiality
obligations.

 

	7.	NON-COMPETITION/NON-SOLICITATION

 

During
the term of his employment hereunder and for the one (1) year period following the termination hereof for any reason other than (a) the
Company’s discontinuance of activities; or (b) an adjudication of the Company’s material breach of any of its obligations
set forth in Sections 1, 2,4, and 5 inclusive, the “Restricted Period”) the Executive shall not, without prior written consent
by the Board of Directors of the Company, directly or indirectly, engage in or become an owner of, render any service to, enter the employment
of, or represent or solicit for any business which competes with any activity of the Company conducted at any time during the Executive’s
period of employment and which is located in the United States. The parties expressly agree that the duration and geographical area of
the restrictive covenant are reasonable.

 

The
covenant shall be construed as an agreement independent of any other provision herein; and the existence of any claim or cause of action
of the Executive against the Company regardless of how arising, shall not constitute a defense to the enforcement by the Company or its
terms. If any portion of the covenant is held by a court to be unenforceable with respect either to its duration or geographical area,
for whatever reason, it shall be considered divisible both as to time and geographical area, resulting in an intended requirement that
the longest lesser period of time or largest lesser geographical area found by such court to be a reasonable restriction shall remain
an effective restrictive covenant, specifically enforceable against the Executive.

 

Notwithstanding
any statement contained in this Section to the contrary, legal or beneficial ownership by the Executive of a less than five percent (5%)
interest in a competitive corporation the stock of which is publicly traded on a stock exchange or by means of an electronic dealer quotation
system, shall not of itself be deemed to constitute a breach by the Executive of the terms hereof.

 

Additionally,
during the Executive’s employment with the Company and thereafter during the Restricted Period, the Executive shall not, and shall
not permit any third party subject to Executive’s direction or control to, directly or indirectly, (i) call upon, accept business
from, or solicit the business of any Person who is, or who had been at any time during the preceding twelve months, a customer of the
Company, (ii) otherwise divert or attempt to divert any business from the Company, (iii) interfere with the business relationships between
the Company and any of its customers, suppliers or others with whom they have business relationships or (iv) recruit or otherwise solicit
or induce, or enter into or participate in any plan or arrangement to cause, any Person who is an employee of, or otherwise performing
services for, the Company to terminate his employment or other relationship with the Company, or hire any Person who has left the employ
of or ceased providing services to the Company during the Restricted Period.

 

    	4

    	 

    

 

	8.	REMEDIES
                                            FOR BREACH OF EXECUTIVE OBLIGATIONS

 

The
parties to the agreement agree that the services of the Executive are of a personal, specific, unique and extraordinary character and
cannot be readily replaced by the Company. They further agree that in the course of performing his services, the Executive will have
access to various types of proprietary information of the Company, which, if released to others or used by the Executive other than for
the benefit of the Company, in either case without the Company’s written consent, could cause the Company to suffer irreparable
injury. Therefore, the obligation of the Executive established under Section 6 and Section 7 hereof shall be enforceable both at law
and in equity, by injunction, specific performance, damages or other remedy; and the right of the Company to obtain any such remedy shall
be cumulative and not alternative and shall not be exhausted by any one or more uses thereof. Any adjudication against Executive by the
Company shall be in accordance with the laws of Massachusetts and Massachusetts employee rights.

 

	9.	MODIFICATION
                                            AND TERMINATION

 

	a.	Modification.
    The Agreement may be amended or modified only with the mutual written consent of the parties, and in its present form consists
    of the entire Agreement between and amongst the parties.
	 	 
	b.	Termination-General.
    The Agreement may be terminated by either party for any reason by giving six (6) months’ notice to the other party. The
    Agreement may be terminated by the Company upon the occurrence of any one of the following events: (a) the death of the Executive;
    (b) the occurrence to Executive of a physical or mental disability which, in the judgment (reasonably exercised) of the Board of
    Directors, renders him unable to perform his normal duties on behalf of the Company for a continuous period of six (6) months (measured
    from the first day of the month immediately following the occurrence of such disability); or (c) a determination by the Board of
    Directors that there is “Cause” (as described in section d below) to terminate Executive’s employment.
	 	 
	c.	By
    Death or Disability. In the event of the Executive’s death, his base compensation otherwise due for the succeeding
    period of time but no less than three (3) full calendar months following his death shall be paid to his designated beneficiary, or
    to his estate if no beneficiary has been designated. In the event of his disability the Executive shall be paid his compensation
    for the succeeding period of time but no less than three (3) months. Thereafter for the succeeding three (3) months shall be treated
    as being on an authorized unpaid leave of absence.
	 	 
	d.	For
    Cause. For purposes of the Agreement, the term “Cause” shall include, but not be limited to (i) the Executive’s
    willful misconduct or gross negligence; (ii) his conscious disregard of his obligations hereunder or of any other duties reasonably
    assigned to him by the Board of Directors; (iii) his repeated conscious violation of any provision of the law, the Company’s
    By-Laws or of its other stated policies, standards, practices, regulations or procedures; (iv) his commission of any act involving
    moral turpitude; (v) a determination that he has demonstrated a dependence upon any addictive substance, including but not limited
    to alcohol, controlled substances, narcotics or barbiturates; or (vi) continued, willful and deliberate non-performance by the Executive
    of his duties hereunder (other than by reason of the Executive’s physical or mental illness, incapacity or disability) which
    has continued for more than 30 days following written notice of such non-performance from the Board of Directors.

 

    	5

    	 

    

 

	e.	Continued
    Effectiveness of Certain Obligations. No termination or expiration of the Agreement, whether consummated by action of either
    party or by operation of the terms hereof, shall relieve the Executive from his continued performance of the obligations established
    under Sections 6 and 7 hereof.
	 	 
	f.	Resignation
    as an Officer or Director.  Immediately upon any termination of Executive’s employment for any reason, Executive
    shall be deemed to have resigned any position he may then hold as an officer of the Company and/or as a fiduciary of any Company
    benefit plan. 

 

	10.	Change
                                            of Control

 

If
Executive’s termination of employment occurs within 3 months prior to or 12 months after a “Change in Control” as defined
in this Section and such termination is by the Company without “Cause,” (i) Executive would be entitled to receive, in lieu
of the severance amount described in Section 4, a severance amount equal to the sum of his current base salary and target annual bonus
for the then current fiscal year (or if higher, the target annual bonus for the fiscal year immediately prior to the Change in Control),
and (ii) Subject to the Executive’s copayment of premium amounts at the active employees’ rate, the Executive may continue
to participate in the Company’s group health, dental and vision program for 12 months; provided, however, that the continuation
of health benefits under this Section shall reduce and count against the Executive’s rights under COBRA.

 

For
the purpose of this Agreement, a “Change in Control” shall mean the occurrence of any of the following events: 

 

	a.	The
    approval by stockholders of the Company of: 
	 	 	 
	 	1.	Any
    consolidation or merger of the Company in which the company is not the continuing or surviving corporation, or 
	 	 	 
	 	2.	A
    sale, lease, exchange or other transfer (in one transaction or a series of related transactions) of all or substantially all the
    assets of the Company to a party which is not controlled by the Company’s parent company; 

 

	b.	Either:
    
	 	 	 
	 	1.	The
    receipt by the Company of a report on schedule 13D, or an amendment to such a report, filed with the Securities and Exchange Commission
    (“SEC”) pursuant to Section 13(d) of the Securities Exchange Act of 1934 (the “1934 Act”) disclosing that
    any person, group, corporation or other entity (a “Person”) is the beneficial owner, directly or indirectly, of 50% or
    more of the outstanding stock of the Company, or 
	 	 	 
	 	2.	The
    actual knowledge by the Company of facts, on the basis of which any person is required to file such a report on schedule 13D, or
    an amendment to such a report, with the SEC (or would be required to file such a report or amendment upon the lapse of the applicable
    period of time specified in Section 13(d) of the 1934 Act) disclosing that such a person is the beneficial owner, directly or indirectly,
    of 50% or more of the outstanding stock of the Company;

 

    	6

    	 

    

 

	c.	The
    purchase by any person (as defined in Section 13(d) of the 1934 Act), corporation or other entity, other than the Company or a wholly
    owned subsidiary or the parent company of the Company, of shares pursuant to a tender or exchange offer, to acquire any stock of
    the Company (or securities convertible into stock) for cash, securities or any other consideration provided that, after consummation
    of the offer, such person, group, corporation or other entity is the beneficial owner (as defined in rule 13d-3 under the 1934 Act),
    directly or indirectly, of 50% or more of the outstanding stock of the Company (calculated as provided in paragraph (d) of Rule 13d-3
    under the 1934 act in the case of rights to acquire stock); or 
	 	 
	d.	The
    combination or merger of the Company with another company in which the Company is the surviving corporation but, immediately after
    the combination, the shareholders of the Company immediately prior to the combination do not hold, directly or indirectly, more than
    50% of the voting stock of the combined company (therefore being excluded from the number of shares held by such shareholders, but
    not from the voting stock of the combined company, any shares received by affiliates (as defined in the rules of the Securities and
    Exchange Commission) of such other company in exchange for stock of such other  company).

 

	11.	INDEBTEDNESS
                                            OF EXECUTIVE

 

If,
during the course of his employment, Executive becomes indebted to the Company for any reason, the Company shall, if it so elects, have
the right to set off and to collect any sums due it from the Executive out of any amounts which it may owe to the Executive for unpaid
compensation. In the event that the Agreement terminates for any reason, all sums owed by the Executive to the Company shall become immediately
due and payable.

 

	12.	MISCELLANEOUS
                                            PROVISIONS

 

	a.	Non-assignment:
    Neither the Agreement nor any right or interest hereunder shall be assigned by the Executive or his legal representatives.
	 	 
	b.	Enforcement:
    If any term or condition or the Agreement shall be invalid or deemed unenforceable to any extent or in any application, then
    the remainder of the Agreement, and such terms or conditions except to such extent or in such application, shall not be affected
    thereby, and each and every term and condition of the Agreement shall be valid and enforced to the fullest extent and in the broadest
    application permitted by law.
	 	 
	c.	Notice:
    All notices or other communications required or permitted to be furnished pursuant to the Agreement shall be in writing and
    shall be considered as delivered when received by the recipient.

 

    	7

    	 

    

 

	d.	Application
    of Massachusetts Law: The Agreement, and the application or interpretation thereof, shall be governed exclusively by its
    terms and by the laws of the State of Massachusetts. Venue shall be deemed located in Middlesex County, Massachusetts.
	 	 
	e.	Counterparts:
    The Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which
    together shall constitute on and the same instrument.
	 	 
	f.	Binding
    Effect: Each of the provisions and agreements herein contained shall be binding upon and inure to the benefit of the personal
    representatives, devisees, heirs, successors, transferees and assigns of the respective parties hereto.
	 	 
	g.	Cooperation:
    During and following the active life of this Agreement, Executive shall give Executive’s assistance and cooperation
    willingly, upon reasonable notice (which shall include due regard to the extent reasonably feasible for Executive’s employment
    obligations and prior commitments), in any matter relating to Executive’s position with the Company or Executive’s knowledge
    as a result thereof as the company may reasonably request, including Executive’s attendance and truthful testimony where deemed
    appropriate by the Company, with respect to any investigation or the Company’s defense or prosecution of any existing or future
    claims or litigations or other proceeding relating to matters in which he was involved or had knowledge by virtue of Executive’s
    employment with the Company. The Company will reimburse Executive for reasonable out-of-pocket travel costs and expenses incurred
    by his (in accordance with Company policy) as a result of providing such assistance. 
	 	 
	h.	Legal
    Fees and Costs: If a legal action is initiated by Executive against the Company, arising out of or relating to the alleged
    performance or non-performance of any right or obligation established hereunder, or any dispute concerning the same, any and all
    fees, costs and expenses reasonably incurred by the Company in investigating, preparing for, defending against, or providing evidence,
    producing documents or taking any other action in respect of, such action shall be the joint and several obligation of and shall
    be paid or reimbursed by Executive only if Executive is the unsuccessful party. If any other legal action (other than that which
    is referenced above) is initiated by a party to the Agreement against another, arising out of or relating to the alleged performance
    or non-performance of any right or obligation established hereunder, or any dispute concerning the same, each party shall be responsible
    for its own fees, costs and expenses reasonably incurred in investigating, preparing for, prosecuting, defending against, or providing
    evidence, producing documents or taking any other action in respect thereof.
	 	 
	i.	Indemnification:
    The Company hereby agrees to indemnify Executive and hold him harmless to the fullest extent permitted by law and under the
    bylaws of the Company against and in respect to any and all actions, suits, proceedings, claims, demands, judgements, costs, expenses
    (including reasonable attorney’s fees), losses, and damages resulting from Executive’s good faith performance of his
    duties and obligations with the Company, except in the case of gross negligence or willful misconduct, whether or not such claims,
    demands, judgements, costs, expenses, losses, and damages are asserted or filed during the active life of this Agreement. 
	 	 
	j.	Survival:
    The Parties’ obligations under Sections 6, 7, 8, 10, 11, and 12 shall survive the Termination of this agreement.

 

    	8

    	 

    

 

IN
WITNESS WHEREOF, the parties have executed the Agreement,

 

	/s/
    Erica Monaco, 8/11/21	 
	Secretary
    of the Board of Directors	 
	 	 
	/s/
    Hermann Luebbert	 
	Hermann
    Luebbert 	 

 

    	9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00332-of-00352.parquet"}]]